Psychopharmacological treatment of obsessive-compulsive disorder (OCD)

A Del Casale, S Sorice, A Padovano… - Current …, 2019 - ingentaconnect.com
Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …

[HTML][HTML] Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

NA Fineberg, E Hollander, S Pallanti… - International clinical …, 2020 - journals.lww.com
In this position statement, developed by The International College of Obsessive-Compulsive
Spectrum Disorders, a group of international experts responds to recent developments in the …

[HTML][HTML] Treatment-resistant OCD: Pharmacotherapies in adults

PJ Van Roessel, G Grassi, EN Aboujaoude… - Comprehensive …, 2023 - Elsevier
Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

[PDF][PDF] Mapping compulsivity in the DSM-5 obsessive compulsive and related disorders: cognitive domains, neural circuitry, and treatment

NA Fineberg, AM Apergis-Schoute… - International Journal …, 2018 - academic.oup.com
Compulsions are repetitive, stereotyped thoughts and behaviors designed to reduce harm.
Growing evidence suggests that the neurocognitive mechanisms mediating behavioral …

Investigating the role of glutamate in obsessive-compulsive disorder: current perspectives

S Karthik, LP Sharma… - … disease and treatment, 2020 - Taylor & Francis
Glutamate is a ubiquitous excitatory neurotransmitter, which is involved in normal
physiology, a variety of central nervous system (CNS) functions, including excitotoxicity and …

Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder

Z Marinova, DM Chuang… - Current …, 2017 - ingentaconnect.com
Objective: Obsessive-compulsive disorder (OCD) is a mental disease commonly associated
with severe distress and impairment of social functioning. Serotonin reuptake inhibitors …

[HTML][HTML] Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients

K Swierkosz-Lenart, JFA Dos Santos, J Elowe… - Frontiers in …, 2023 - frontiersin.org
Even though obsessive compulsive disorder (OCD) is one of the ten most disabling
diseases according to the WHO, only 30–40% of patients suffering from OCD seek …

Ketamine in the treatment of obsessive-compulsive disorder: a systematic review

ID Bandeira, DH Lins-Silva, VB Cavenaghi… - Harvard review of …, 2022 - journals.lww.com
Methods This systematic review aims to investigate the effects of ketamine in OCD, following
the Preferred Reporting Items for Systematic Review and Meta-analyses Protocols (PRISMA …

Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis

DD Zhou, XX Zhou, Y Li, KF Zhang, Z Lv… - Progress in Neuro …, 2019 - Elsevier
Background Various agents for augmentation of serotonin reuptake inhibitors have been
investigated for treatment-resistant obsessive-compulsive disorder (OCD). We aimed to …

Investigational and experimental drugs to treat obsessive-compulsive disorder

G Grassi, C Cecchelli, L Vignozzi… - Journal of Experimental …, 2021 - Taylor & Francis
Abstract Treatment-resistance is a frequent condition for obsessive-compulsive disorder
(OCD). Over the past decades, a lot of effort has been made to address this issue, and …